From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 99 Pages
Saudi Arabia
From €4148EUR$4,500USD£3,494GBP
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 98 Pages
Philippines
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 88 Pages
Indonesia
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 89 Pages
Qatar
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 88 Pages
Kuwait
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 94 Pages
Saudi Arabia
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 80 Pages
Saudi Arabia
From €4148EUR$4,500USD£3,494GBP
- Report
- October 2025
- 150 Pages
Global
From €5484EUR$5,950USD£4,620GBP
- Report
- September 2025
- 140 Pages
Global
From €4470EUR$4,850USD£3,766GBP
- Report
- September 2025
- 114 Pages
Global
From €4286EUR$4,650USD£3,611GBP
- Report
- September 2025
- 94 Pages
Global
From €16587EUR$17,995USD£13,973GBP
- Report
- August 2025
- 112 Pages
Global
From €3180EUR$3,450USD£2,679GBP
- Report
- August 2025
- 81 Pages
Middle East, Africa
From €3180EUR$3,450USD£2,679GBP
- Report
- August 2025
- 81 Pages
From €3180EUR$3,450USD£2,679GBP
- Report
- August 2025
- 96 Pages
Asia Pacific
From €3641EUR$3,950USD£3,067GBP
- Report
- August 2025
- 100 Pages
Europe
From €3641EUR$3,950USD£3,067GBP
- Report
- August 2025
- 89 Pages
North America
From €3180EUR$3,450USD£2,679GBP
- Report
- August 2025
- 197 Pages
Global
From €4563EUR$4,950USD£3,844GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more